These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

700 related items for PubMed ID: 24105727

  • 1. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
    Liao GD, Sellors JW, Sun HK, Zhang X, Bao YP, Jeronimo J, Chen W, Zhao FH, Song Y, Cao Z, Zhang SK, Xi MR, Qiao YL.
    Int J Cancer; 2014 Apr 01; 134(7):1715-24. PubMed ID: 24105727
    [Abstract] [Full Text] [Related]

  • 2. Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study.
    Razmpoosh M, Sansregret A, Oligny LL, Patey N, Dormoy-Raclet V, Ducruet T, Bouron-Dal Soglio D.
    Am J Clin Pathol; 2014 Jul 01; 142(1):104-10. PubMed ID: 24926093
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of p16-INK4A protein in women with negative or CIN1 histology result: a follow-up study.
    Pacchiarotti A, Ferrari F, Bellardini P, Chini F, Collina G, Dalla Palma P, Ghiringhello B, Maccallini V, Musolino F, Negri G, Pisa R, Sabatucci I, Giorgi Rossi P.
    Int J Cancer; 2014 Feb 15; 134(4):897-904. PubMed ID: 23913416
    [Abstract] [Full Text] [Related]

  • 4. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
    Dray M, Russell P, Dalrymple C, Wallman N, Angus G, Leong A, Carter J, Cheerala B.
    Pathology; 2005 Apr 15; 37(2):112-24. PubMed ID: 16028838
    [Abstract] [Full Text] [Related]

  • 5. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I].
    Wang R, Li X, Qian M, Niu J, You Z.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar 15; 50(3):210-5. PubMed ID: 26268412
    [Abstract] [Full Text] [Related]

  • 6. Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents.
    Hu L, Guo M, He Z, Thornton J, McDaniel LS, Hughson MD.
    Mod Pathol; 2005 Feb 15; 18(2):267-73. PubMed ID: 15492761
    [Abstract] [Full Text] [Related]

  • 7. Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial.
    Carozzi F, Gillio-Tos A, Confortini M, Del Mistro A, Sani C, De Marco L, Girlando S, Rosso S, Naldoni C, Dalla Palma P, Zorzi M, Giorgi-Rossi P, Segnan N, Cuzick J, Ronco G, NTCC working group.
    Lancet Oncol; 2013 Feb 15; 14(2):168-76. PubMed ID: 23261355
    [Abstract] [Full Text] [Related]

  • 8. [Clinical value of p16INK4a immunocytochemistry in cervical cancer screening].
    Song FB, Du H, Xiao AM, Wang C, Huang X, Yan PS, Liu ZH, Qu XF, Belinson JEROMEL, Wu RF.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov 25; 55(11):784-790. PubMed ID: 33228350
    [Abstract] [Full Text] [Related]

  • 9. Characterization of cervical biopsies of women with HIV and HPV co-infection using p16ink4a, ki-67 and HPV E4 immunohistochemistry and DNA methylation.
    Kremer WW, Vink FJ, van Zummeren M, Dreyer G, Rozendaal L, Doorbar J, Bleeker MCG, Meijer CJLM.
    Mod Pathol; 2020 Oct 25; 33(10):1968-1978. PubMed ID: 32249820
    [Abstract] [Full Text] [Related]

  • 10. High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study.
    Tsoumpou I, Valasoulis G, Founta C, Kyrgiou M, Nasioutziki M, Daponte A, Koliopoulos G, Malamou-Mitsi V, Karakitsos P, Paraskevaidis E.
    Gynecol Oncol; 2011 Apr 25; 121(1):49-53. PubMed ID: 21194734
    [Abstract] [Full Text] [Related]

  • 11. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.
    Coll Antropol; 2010 Mar 25; 34(1):19-24. PubMed ID: 20432728
    [Abstract] [Full Text] [Related]

  • 12. Relationship between p16/ki67 immunoscores and PAX1/ZNF582 methylation status in precancerous and cancerous cervical lesions in high-risk HPV-positive women.
    Luo H, Lian Y, Tao H, Zhao Y, Wang Z, Zhou J, Zhang Z, Jiang S.
    BMC Cancer; 2024 Sep 20; 24(1):1171. PubMed ID: 39304838
    [Abstract] [Full Text] [Related]

  • 13. Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias.
    Venturoli S, Ambretti S, Mirasoli M, Santini D, Zerbini M, Roda A, Musiani M.
    Int J Gynecol Pathol; 2008 Oct 20; 27(4):575-81. PubMed ID: 18753961
    [Abstract] [Full Text] [Related]

  • 14. Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.
    Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, De Marco L, Giorgi-Rossi P, Pontenani G, Rosso S, Sani C, Sintoni C, Segnan N, Zorzi M, Cuzick J, Rizzolo R, Ronco G, New Technologies for Cervival Cancer Screening (NTCC) Working Group.
    Lancet Oncol; 2008 Oct 20; 9(10):937-45. PubMed ID: 18783988
    [Abstract] [Full Text] [Related]

  • 15. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
    van Baars R, Griffin H, Wu Z, Soneji YJ, van de Sandt M, Arora R, van der Marel J, Ter Harmsel B, Jach R, Okon K, Huras H, Jenkins D, Quint W, Doorbar J.
    Am J Surg Pathol; 2015 Nov 20; 39(11):1518-1528. PubMed ID: 26379150
    [Abstract] [Full Text] [Related]

  • 16. The triage of low-grade cytological abnormalities by the immunocytological expression of cyclin-dependent kinase inhibitor p16INK4a versus Human Papillomavirus test: a real possibility to predict cervical intraepithelial neoplasia CIN2 or CIN2+.
    Stănculescu R, Brătilă E, Bauşic V, Vlădescu T.
    Rom J Morphol Embryol; 2013 Nov 20; 54(4):1061-5. PubMed ID: 24399002
    [Abstract] [Full Text] [Related]

  • 17. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M, Gotlieb W, Gilbert L, Hemmings R, Behr MA, Franco EL, STAIN-IT Study Group.
    Int J Cancer; 2021 Jan 15; 148(2):492-501. PubMed ID: 32781481
    [Abstract] [Full Text] [Related]

  • 18. Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.
    Polman NJ, Uijterwaal MH, Witte BI, Berkhof J, van Kemenade FJ, Spruijt JW, van Baal WM, Graziosi PG, van Dijken DK, Verheijen RH, Helmerhorst TJ, Steenbergen RD, Heideman DA, Ridder R, Snijders PJ, Meijer CJ.
    Int J Cancer; 2017 Jan 15; 140(2):423-430. PubMed ID: 27677098
    [Abstract] [Full Text] [Related]

  • 19. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Ovestad IT, Dalen I, Hansen E, Loge JL, Dybdahl BM, Dirdal MB, Moltu P, Berland JM.
    Cancer Cytopathol; 2017 Apr 15; 125(4):283-291. PubMed ID: 27918650
    [Abstract] [Full Text] [Related]

  • 20. p16INK4A immunoexpression and HPV in situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial neoplasia.
    Kalof AN, Evans MF, Simmons-Arnold L, Beatty BG, Cooper K.
    Am J Surg Pathol; 2005 May 15; 29(5):674-9. PubMed ID: 15832093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.